Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-075376
Filing Date
2020-06-19
Accepted
2020-06-19 21:07:34
Documents
1
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2023095-1_3.html 3  
1 OWNERSHIP DOCUMENT tm2023095-1_3.xml 3 4908
  Complete submission text file 0001104659-20-075376.txt   6895
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39335 | Film No.: 20977036

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39335 | Film No.: 20977037

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Issuer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations